Abstract
Purpose
Since some patients develop depigmentation of the trabecular meshwork in the course of Vogt–Koyanagi–Harada (VKH) disease, we examined the incidence of trabecular depigmentation and its correlation with other ocular findings and systemic symptoms.
Methods
We retrospectively reviewed the clinical charts of 53 Japanese patients diagnosed with VKH disease. The scores of trabecular and limbal pigmentation of all patients were recorded. We then examined the correlation between trabecular pigmentation and the presence of sunset glow fundus or skin lesions.
Results
Trabecular pigmentation was significantly lower in the patients with sunset glow fundus than in those without it (P = 0.022), whereas limbal pigmentation showed no significance. However, there were no significant differences in trabecular and limbal pigmentation between the patients with and those without skin lesions. Furthermore, there was no correlation between trabecular and limbal pigmentation.
Conclusions
Depigmentation of the trabecular meshwork develops in some patients in the course of VKH disease. This depigmentation is significantly correlated with sunset glow fundus, but not with limbal depigmentation or skin lesions.
Similar content being viewed by others
References
Goto H, Rao NA. Sympathetic ophthalmia and Vogt–Koyanagi–Harada syndrome. Int Ophthalmol Clin. 1990;30:279–85.
Sugiura S. Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol. 1978;22:9–35.
Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt–Koyanagi–Harada disease. Br J Ophthalmol. 1996;80:1002–8.
Rao NA. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye (London). 1997;11:213–6.
Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt–Koyanagi–Harada disease. Int Immunol. 1996;8:799–803.
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–52.
Moorthy RS, Inomata H, Rao NA. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995;39:265–92.
Scheie HG. Width and pigmentation of the angle of the anterior chamber; a system of grading by gonioscopy. AMA Arch Ophthalmol. 1957;58:510–2.
Saari JM, Nummelin K. Iris atrophy, serous detachment of the ciliary body, and ocular hypotony in chronic phase of Vogt–Koyanagi–Harada disease. Eur J Ophthalmol. 2005;15:277–83.
Suhler EB, Buggage RR, Nussenblatt RB, Neumann R. Symmetric peripheral iris depigmentation in Vogt–Koyanagi–Harada syndrome. Arch Ophthalmol. 2002;120:1104–5.
Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt–Koyanagi–Harada disease. J Immunol. 2000;165:7323–9.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mizuuchi, K., Kitaichi, N., Namba, K. et al. Trabecular meshwork depigmentation in Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol 57, 245–251 (2013). https://doi.org/10.1007/s10384-012-0229-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-012-0229-1